Best THCA Flower of May 2025: Newly Launched Strains By Exhale Wellness
Exhale's Newly Launched THCA Flower Strains are hitting the markets in May 2025. Here's a detailed review of top varieties: Snow Caps & Space Junkie!
Charlotte, May 16, 2025 (GLOBE NEWSWIRE) -- Two newly launched THCA flower strains from Exhale Wellness are gaining early attention for their potency, quality, and visual appeal, positioning the brand as a leader in the rapidly expanding 2025 hemp market. The constant buzz around these releases highlights consumers' growing interest in effective, full-spectrum THCA products.
Unlike other traditional cannabinoids like THC and CBD, THCA offers dual functionality. It can be enjoyed in raw form solely for wellness-focused effects or heated to mimic the psychoactive effects of Delta 9 THC. This flexibility is helping THCA flower carve out a distinct niche among both wellness users and recreational consumers.
What is THCA Flower?
THCA flowers are hemp flowers containing massive THCA (Tetrahydrocannabinolic acid) content, usually accompanied by minimal amounts of THC. Owing to high THCA content, which is a non-psychocative hemp compound, THCA flower is considered therapeutic and non-intoxicating when consumed raw.
However, the game changes when the flower is baked, as exposure to heat initiates a decarboxylation process that converts THCA into THC, generating fumes and smoke rich in Delta-9 THC, a potent psychoactive cannabis compound. As a result, the effects are more mind-altering and intense than raw flower.
Regardless of how it's used, THCA flower is generally considered effective in relieving pain, reducing anxiety, and soothing overall discomfort owing to its anti-inflammatory and analgesic properties.
Best THCA Flower Strains Launched by Exhale
Shopping for top-tier THCA flower online in 2025 comes with more choices than ever, making it tough to tell what's truly worth your time and money. But as of right now, two newly launched strains from Exhale Wellness are getting all the attention:
- Snow Caps Strain
THCA Flower - Space Junkie
These new strains are lab-tested and being consistently praised across social platforms for their potency and smooth effects. Let's break down what's making them shine!
#1. - Snow Caps
Snow Caps are quickly making waves as one of the freshest exotic THCA flower drops in May 2025, for good reason. Early buzz from the community and customer feedback highlights these trichome-heavy buds for their stunning visual appeal and boosted potency that's already turning heads.Plus, their unique composition makes them stand out among the existing strains. The preparation starts with premium THCA hemp flower being plucked from an indoor-grown hemp plant, then coated in pure hemp-derived THCA isolate powder, giving it that signature snow-dusted look and delivering a 10–20% potency boost over standard THCA strains. Fans are already calling it 'frosted' and 'crystal-rich,' with many saying the look alone screams premium quality.
Specifications
Net Weight: 3.5 grams per jar
Cannabinoids: Coated in ultra-pure THCa Diamonds for maximum potency
THCA Strength: 40%
Potency: 800mg of THCa per jar
Compliance: Federally legal under the 2018 Farm Bill (contains ≤ 0.3% Delta-9 THC)
Hemp Source: Responsibly cultivated from USA-grown hemp
Lab Verified: Tested by third-party labs to ensure purity, potency, and safety
Visual Profile: Frosted appearance from crystallized THCa coating
Strain Lineage: Godfather OG, known for deeply calming, indica-dominant effects
Packaging: Sealed in airtight jars to preserve freshness and terpene profile
Dosage
If you're determined to try it, now's the best time! Consider starting low and going slow, especially given the product's high THCa concentration. Each jar contains 800mg of THCa, so even a small amount can go a long way.
Begin with just a small pinch for raw use, such as in smoothies, salads, or herbal teas. If you're smoking or vaping, we recommend starting with a single light bowl or one short vape session to gauge your tolerance. The potency can build quickly, and the Godfather OG strain is known for its deeply relaxing, body-heavy effects.
As always, the exact dosage depends on how your body tolerates and responds to the strain. So, after use, allow time (30–60 minutes) to evaluate how you feel before considering increasing or going for the next dose.
Pros
Works raw, smoked, or in mixed edibles
Rich flavor makes it a favorite among seasoned cannabis users
Strong supportive effects for those managing long-term stress or soreness
Compliant with federal guidelines, easy to buy online
Helpful for tension and low mood when decarbed
Cons
May feel intense for those with low tolerance
Accessible only to those aged above 21 years
Reviews
John D. – Austin, TX: 'Exhale's Godfather OG is my go-to THCA strain for back pain. It works almost instantly—just a few hits and I feel the tension melt away. Easily one of the most relaxing strains I've tried.'
Samantha T. – Portland, OR: 'Strong stuff. Definitely better suited for nighttime or when you have nothing on your schedule. One small bowl and I'm completely at ease.'
#2.
Space Junkie THCa Flower is one of Exhale's newest sativa standouts to hit the scene in May 2025, and it's already making a name for itself among hemp lovers. With buds that look more like something from another galaxy than your typical flower, this freshly launched strain features a bold mix of deep purples and neon lime greens, wrapped in a thick coat of shimmering trichomes that give it a true space-age glow.
But Space Junkie isn't just eye candy, it packs a flavorful punch, too, claim may of its first users. They rave about its complex, terpene-rich aroma, with sharp notes of citrus, sweet cream, and a subtle skunky twist. Once lit, it transforms into a zesty combo of grapefruit, tart lemonade, and earthy undertones. Clocking in at over 36% THCa, Space Junkie has broken the glass ceiling one of the most potent new legal hemp strains available under the 2018 Farm Bill, quickly becoming a fan favorite.
Specifications
Strain: Space Junkie (Sativa)
THCA Strength: Above 36%
Flavor Profile: Fruity with tropical and spicy notes, hints of Grapefruit and Lemonade
Effects: Happy mood, increased energy, clearer focus
Ideal Growing: Flexible for indoor or mild outdoor conditions
Difficulty to Grow: Easy to moderate, good option for beginners and home growers
Subscription Benefits: Save Up to 30%
Shipping: Restricted to legal states; free for orders above $80.00
Dosage
Willing to give it a try? As a first-time user, we advise you to approach it with mindful moderation. Start with a small amount, roughly a pinch or a single bowl, especially if you're using it during the morning or early afternoon.
Inhaled in low doses, this flower tends to support mental clarity, sociability, and motivation, making it ideal for work sessions, creative tasks, or adventures. Some who've already experienced its rich potency have found that slightly larger doses can promote an almost euphoric energy.
Pros suggest that due to its stimulating nature, Exhale's Space Junkie can best be enjoyed earlier in the day. Taking higher doses in the late afternoon or evening may interfere with your natural sleep cycle. It's crucial to wait 10–20 minutes after the first dose and evaluate the effects before consuming more.
Pros
Natural boost without feeling jittery
Flavorful, unique strain appreciated by fans of fruity varieties
Helps with low energy and getting through big tasks
Buy THCA flower online at Exhale with legal compliance
Flexible use; offers non-intoxicating and psychoactive options in one flower
Cons
May feel alert too late in the day
Fruity flavors aren't everyone's first choice
Reviews
Emily A., Portland, OR: 'Nothing gets me feeling sharp in the morning like Space Junkie THCA strain. It's light on the body but keeps my focus dialed in. A great pick-me-up when coffee just doesn't cut it.'
Marc L., Atlanta, GA: 'Good overall experience, especially for staying motivated during the day. The sweet citrus aftertaste isn't totally my thing, but the uplifting effects make up for it. I'd recommend it for light daytime use.'
Benefits of Consuming the Best THCa Flower
These days, the best THCa flower is praised not just for its potency or flavor, but also for its potential wellness perks. Here are some of its most talked-about advantages out there:
Promotes relaxation and stress relief: Top-tier THCa flower is often praised for its calming effects, especially when heated. Users report feeling more mentally at ease, making it a popular choice for winding down after a long day or managing general anxiety. It may support a mellow state without heavy sedation.
May help with pain management: THCa is non-psychoactive in its raw form, but may offer relief when decarboxylated. Many users turn to it for support with chronic pain, joint stiffness, and muscle tension. This makes THCa flower a preferred option for natural, plant-based pain management routines.
Supports better sleep quality: Certain THCa strains may help promote restful sleep when taken in moderate evening doses. Users often experience easier sleep onset and fewer nighttime interruptions. The physical relaxation paired with mild mental calmness can create the right environment for deep rest.
Enhances mood and overall well-being: Uplifting sativa-dominant strains are especially noted for boosting mood. Many users report feeling more positive, alert, and motivated after consumption. THCa flower may help improve emotional balance without overwhelming psychoactive effects, whether used in social settings or solo.
Things to keep in Mind before having your Best THCA flower
Before adding THCa flower to your routine, you must make informed decisions to ensure a safe and enjoyable experience. From proper storage to legal awareness and dosage control, these tips offered by modern cannbis users can help you get the most out of your THCa use:
Start with a low dose, especially if you're a beginnerTHCa flower can have strong effects when heated, so new users should begin with a small amount. Starting low allows you to gauge your body's response and avoid overwhelming sensations. Gradually increasing your dosage helps ensure a balanced and comfortable experience.
Understand the difference between raw and heated (decarbed) THCaRaw THCa is non-psychoactive and often used for its potential anti-inflammatory and wellness benefits. Heating it through smoking, vaping, or baking activates THC, leading to more noticeable effects. Knowing how you plan to consume THCa helps you predict its impact more accurately.
Be aware of local laws and regulations regarding THCa productsLaws around THCa vary across states and can change frequently. While federally legal under the Farm Bill, some states restrict or ban THCa flower. Always check your local and state regulations to stay compliant and avoid legal trouble when purchasing or using THCa products.
Choose high-quality, organically grown flowersThe purity and potency of THCa flower depend on how it's grown and processed. Look for lab-tested, organically cultivated strains from reputable sources. Quality flowers not only taste and smell better, but also minimize your exposure to harmful pesticides or contaminants.
Consider possible interactions with medicationsTHCa may affect how your body processes certain medications, especially those for blood pressure, mood, or immune response. If you take prescription drugs regularly, talk to your doctor first. Being cautious helps prevent unwanted side effects or reduced effectiveness of your medication.
Store the flower in a cool, dry place to preserve potencyHeat, light, and moisture can degrade the cannabinoids and terpenes in THCa flower over time. Keep your jar sealed in a dark, cool spot to maintain freshness and effectiveness. Proper storage also prevents mold and extends the shelf life of your flowers.
Consult a healthcare professional if you have health conditionsIf you have underlying conditions like heart disease, mental health concerns, or immune disorders, it's best to consult a medical professional before using THCa. They can offer personalized advice based on your health history.
How to Choose the Best THCa Flower?
When selecting the best THCa flower for use in May 2025, you need to consider several essential factors that help ensure you're getting a premium, safe, and effective product. Below are key aspects to keep in mind when making your choice:
Third-party lab-tested productsThird-party lab testing is one of the most reliable indicators of quality when choosing THCa flower. Independent labs assess the flower for cannabinoid content, ensuring accurate THCa levels.
These tests also screen for harmful contaminants like pesticides, molds, and heavy metals that could affect your health. Lab reports, often available on the brand's website, provide transparency and give you confidence that the product is safe, pure, and potent. If a company doesn't provide lab results, it's best to look elsewhere.
Hassle-free deliveryThe convenience of delivery plays a significant role in your purchasing experience. A trustworthy brand should offer smooth, hassle-free shipping with transparent policies regarding delivery times and fees.
Many brands also provide tracking numbers so you can follow your order from shipment to arrival. Ensuring that the flower is packaged securely and delivered quickly means you receive your product in perfect condition, without unnecessary delays, and can enjoy your THCa flower without worry.
Potency of the productsPotency refers to the concentration of THCa in the flower, and it's one of the most critical factors to consider. Potency affects the strength of the effects you'll experience. High-potency flowers, which typically contain a higher percentage of THCa, may deliver more intense effects, both physically and mentally, than those with lower concentrations.
Depending on your tolerance and goals, you'll want to choose a product with the right level of potency to achieve your desired results, whether you're seeking subtle relief or more robust effects.
Non-GMONon-GMO (Genetically Modified Organisms) flowers are those grown without the use of genetic engineering. Non-GMO products are typically grown in more natural conditions, ensuring the plants retain their authentic genetic profiles.
Many consumers prefer non-GMO flowers because they align with sustainable farming practices and a healthier approach to cannabis cultivation. Additionally, non-GMO flowers are less likely to have undergone artificial modifications that could compromise their quality or safety, offering peace of mind to those who prioritize organic or eco-conscious choices.
Customer SatisfactionCustomer reviews and ratings offer invaluable insight into a product's real-world quality. A brand that consistently delivers a high level of customer satisfaction will likely have positive reviews across multiple platforms. Look for feedback regarding the flower's effects, taste, aroma, and overall experience.
If many customers report similar positive experiences, it's a good indicator that the product is reliable. Companies that prioritize customer satisfaction also tend to have responsive support teams and offer guarantees or return policies, enhancing your trust in the brand.
FAQs on the Best THCa Flower
Does THCa flower get you high?THCa flower itself does not produce a psychoactive effect because THCa is non-intoxicating in its raw form. However, when heated (e.g., through smoking or vaping), THCa converts to THC, which can lead to a high. So, the raw flower won't get you high, but decarbing it will.
How do you use THCa flowers?THCa flowers can be used in a variety of ways. You can consume them raw, typically by adding them to smoothies or teas, for a non-psychoactive effect. Alternatively, when vaporized or smoked, the THCa converts to THC, offering a more potent, euphoric experience with its energetic and uplifting effects.
Can I fail a drug test using THCa flower?It's unlikely to fail a drug test from using raw THCa flower because it contains very little to no Delta-9 THC. However, if you decarb the flower (by smoking or vaping it), the THCa will convert to THC, which could show up on a drug test, depending on the amount consumed.
How should I store THCa flower?Store THCa flower in a cool, dry place away from direct sunlight and moisture to preserve its potency. Using an airtight container, such as a glass jar, is ideal. Proper storage prevents degradation of cannabinoids and ensures the flower remains fresh and effective for a longer period.
How is THCa flower different from regular THC flower?THCa flower is the raw, non-psychoactive version of THC flower. It contains tetrahydrocannabinolic acid (THCa), which doesn't produce a high. When heated, THCa converts into THC, the compound responsible for the euphoric effects. Regular THC flower, on the other hand, already has THC and is psychoactive.
Is THCa flower safe?THCa flower is generally safe to consume, especially when sourced from reputable growers and third-party lab-tested for quality. It is non-psychoactive when used raw, making it a safer option for those who seek therapeutic effects without the high. However, it's important to be mindful of personal health conditions and consult a doctor if unsure.
How do I choose the best THCa flower?To choose the best THCa flower, prioritize products that are third-party lab-tested for quality, potency, and purity. Look for flowers grown organically without pesticides, and check for customer reviews for insights on flavor and effectiveness. Also, ensure that the flower complies with legal regulations and is sourced from trusted, transparent brands.
What's the Best Place to Buy THCa Flower From?
As per 10K+ customers, Exhale Wellness is the best place to buy THCa flower online in May 2025. Their newly launched lineup offers organically grown, non-GMO products thoroughly lab-tested for purity and quality. Plus, their new and existing customers unanimously appreciate their seamless shopping experience with fast, reliable delivery and responsive customer support, ensuring customer satisfaction at every stage.
CONTACT: Company Name: Exhale Wellness Website: https://exhalewellness.com Contact Person: Exhale Wellness Support Team Email: support@exhalewell.com Contact Number: (323) 448-3810 Country: United States
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
20 hours ago
- Business Upturn
Novo Nordisk: Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA
By GlobeNewswire Published on June 21, 2025, 04:38 IST Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA Results from the phase 3b STEP UP trial showed that a higher dose of Wegovy ® (semaglutide 7.2 mg) delivered 21% weight loss in people with obesity, with a third of participants losing 25% or more of their weight, compared to placebo 1 (semaglutide 7.2 mg) delivered 21% weight loss in people with obesity, with a third of participants losing 25% or more of their weight, compared to placebo Safety and tolerability of the higher dose of Wegovy ® (semaglutide 7.2 mg) was consistent with the currently approved dose (semaglutide 2.4 mg) 1 (semaglutide 7.2 mg) was consistent with the currently approved dose (semaglutide 2.4 mg) The STEP UP data add to the existing evidence base on the value of Wegovy® in delivering significant weight loss and health gains for people living with obesity Bagsværd, Denmark, 21 June 2025 – Novo Nordisk today presented the results from the phase 3b STEP UP trial in people with obesity without diabetes at the American Diabetes Association (ADA) Scientific Sessions, in Chicago, US. In the STEP UP trial, the higher dose of Wegovy® (semaglutide 7.2 mg) demonstrated a mean weight loss of 21%, with a third of participants losing 25% or more of their body weight compared to placebo at 72 weeks.1 'The STEP UP trial demonstrated that we can increase the dose of semaglutide and achieve greater weight loss than previously seen, and in line with semaglutide's established safety profile. This may offer another option to people who do not attain their weight goals,' said Sean Wharton, lead study author and medical director of the Wharton Medical Clinic, Canada. 'We are already aware that semaglutide can have health benefits for people with heart disease, liver disease, knee osteoarthritis, type 2 diabetes and prediabetes. These findings help to give patients with obesity more options for improvements in their weight and overall health.' STEP UP co-primary endpoints at 72 weeks *1 : semaglutide 7.2 mg semaglutide 2.4 mg PlaceboWeight loss 20.7% 17.5% 2.4% 5% or more weight loss 93.2% 92.5% 35.7% When evaluating the effect of treatment regardless of treatment adherence, people receiving semaglutide 7.2 mg achieved 18.7% weight loss vs 3.9% with placebo, and 90.7% achieved 5% or more weight loss with semaglutide 7.2 mg vs 36.8% on placebo. 'With these results, semaglutide reaffirms its significant weight loss for people with obesity. The STEP UP trial delivers a substantial weight loss of over 20%, in addition to health benefits previously demonstrated with semaglutide,' said Ludovic Helfgott, executive vice president of Product & Portfolio Strategy at Novo Nordisk. 'As pioneers in obesity, we continue to develop new innovative treatments to fit the needs and preferences of people living with obesity. This includes maximising the value of semaglutide for individuals, healthcare systems and society, and developing a new oral formulation of Wegovy® that, pending FDA approval, can become the first GLP-1 pill to offer double-digit weight loss.' In the STEP UP trial, semaglutide 7.2 mg demonstrated a well-tolerated safety profile consistent with previous Novo Nordisk semaglutide trials.1 The most common adverse events were gastrointestinal, and the vast majority were mild to moderate during dose escalation and diminished over time, consistent with the GLP-1 class.1 In STEP UP, 3.3% of people treated with semaglutide 7.2 mg discontinued due to gastrointestinal adverse events, compared to 2.0% with semaglutide 2.4 mg and 0% with placebo.1 Novo Nordisk expects to file the higher dose of Wegovy® for a label update in the EU in the second half of 2025, followed by regulatory submissions in other markets where Wegovy® is already approved. STEP UP selected confirmatory secondary endpoints at 72 weeks * 1 : semaglutide 7.2 mg semaglutide 2.4 mg Placebo10% or more weight loss 86.0% 77.6% 20.0%15% or more weight loss 70.4% 57.5% 7.9%20% or more weight loss 50.9% 35.1% 2.9% 25% or more weight loss 33.2% 16.7% 0% * Based on the trial product estimand: treatment effect if all people adhered to treatment. About the STEP UP trials Novo Nordisk has completed two trials, STEP UP and STEP UP T2D, investigating the efficacy and safety of semaglutide 7.2 mg in people with obesity with or without type 2 diabetes. The 72-week STEP UP trial was a randomised, double-blinded, parallel-group, placebo-controlled, superiority trial designed to evaluate the efficacy and safety of semaglutide 7.2 mg compared to semaglutide 2.4 mg and placebo as an adjunct to lifestyle intervention. The trial included 1,407 adults with a BMI ≥30 kg/m2 without diabetes. The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss. Key confirmatory secondary endpoints included the number of participants achieving 10%, 15%, 20% and 25% weight loss, respectively. The 72-week STEP UP T2D trial investigated semaglutide 7.2 mg in 512 adults with obesity and type 2 diabetes, with the primary objective to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss. About Wegovy® Semaglutide 2.4 mg is marketed under the brand name Wegovy®. In the EU, Wegovy® is indicated as an adjunct to a reduced calorie diet and increased physical activity for weight management in adults with a BMI of 30 kg/m2 or greater (obesity) or adults with a BMI of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition. In the EU, Wegovy® is also indicated for paediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and gender (obesity) and body weight above 60 kg. The clinical section of the label also includes data on Wegovy® major adverse cardiovascular events (MACE) risk reduction, improvements in HFpEF-related symptoms and physical function, as well as pain reduction related to knee osteoarthritis. In the US, Wegovy® is indicated in combination with a reduced calorie diet and increased physical activity to reduce the risk of MACE in adults with established cardiovascular disease and either obesity or overweight, as well as to reduce excess body weight and maintain weight reduction long term in paediatric patients aged 12 years and older with obesity and in adults with obesity or with overweight in the presence of at least one weight-related comorbid condition. About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 77,400 people in 80 countries and markets its products in around 170 countries. For more information, visit , Facebook , Instagram , X , LinkedIn and YouTube . Contacts for further information References Wharton, S, et al. (2025). Once-weekly semaglutide 7.2 mg in adults with obesity: the randomised, controlled, phase 3b STEP UP trial. 1966-LB poster. American Diabetes Association (ADA) 85th Scientific Sessions, Chicago, US, June 20 – 23, 2025.17. Attachment Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
20 hours ago
- Business Upturn
ImpactLife shares highlights from World Sickle Cell Disease Awareness Day event
Davenport, Iowa, June 20, 2025 (GLOBE NEWSWIRE) — ImpactLife hosted a special event at its Davenport, Iowa headquarters to recognize World Sickle Cell Disease Awareness Day as part of local celebrations of the Juneteenth federal holiday. The Juneteenth holiday — commemorating the emancipation of enslaved people in the United States — is also recognized as World Sickle Cell Awareness Day with the goal to increase public knowledge of sickle cell disease and the challenges experienced by patients and caregivers. Community members and blood center employees gathered on Thursday, June 19, to learn about the importance of blood transfusions in providing supportive care for sickle cell patients and to hear personal experiences from those who live with sickle cell disease, or who have lost loved ones to the genetically inherited blood disorder. Speakers included Beleta Rush, who shared writings and experiences from the lives of her two daughters, Lynn and Bobbie. View and download video clips from the event, below, or on the ImpactLife web site. Dr. Meredith Parsons, Clinical Assistant Professor of Pathology from University of Iowa, provided an overview on sickle cell disease, how it affects patients, and the importance of having appropriately matched units of blood available for patients who are likely to receive multiple rounds of blood transfusions throughout their lives. Shyneeta Rush, Supervisor, Donor Services, described the blood center's Red4Life program and efforts by the blood center to identify donors who are an appropriate match for sickle cell disease patients. Cheryl Easley, of the ImpactLife donor scheduling team, helped organize the event, and recognized sickle cell 'Warriors In Battle' as well as 'Winged Warriors,' who have passed after living with the disease throughout their lives. Lamour Bluitt has two sisters living with sickle cell disease, and has authored a book on their experiences, A Child Born with Sickle Cell: the Untold Secret. About Sickle Cell Disease Sickle dell disease is an inherited blood disorder that affects red blood cells. It is the most common hereditary disorder and currently affects more than 100,000 Americans, predominantly people of African descent. The red blood cells in patients with sickle cell disease can become 'sickled' in shape, which can cause the cells to become stuck in small blood vessels. Patients can experience pain and anemia and are at increased risk for strokes and other types of organ damage. When patients experience a sickle cell crisis, red cell transfusion is a major form of therapy to relieve symptoms. Patients with sickle cell disease frequently receive transfusions of red blood cells to help treat symptoms of a sickle cell crisis. But finding appropriately matched units for sickle cell disease patients is a challenge for blood providers. With more frequent blood transfusions, patients with sickle cell disease can develop antibodies that are directed against red blood cell antigens. This process, called alloimmunization, makes it important for patients to receive antigen-negative blood types that are more generally found in donors of African descent. To help increase the diversity of the blood center's donor base, ImpactLife has created a donor program called Red4Life. Under Red4Life, the blood center identifies and recruits donors who may be an appropriate antigen match for patients with sickle cell disease. These donors are then invited to join the Red4Life program and receive special donor rewards and additional points to use in the ImpactLife Donor Loyalty Store. (Learn more at About ImpactLife ImpactLife's mission is to save lives by engaging donors, supporting partners, and advancing medicine. Founded in 1974, ImpactLife supplies blood products and services to hundreds of hospitals, emergency services organizations, clinical researchers, and other blood centers throughout Iowa, Illinois, Wisconsin, and Missouri. The nonprofit blood provider is ranked among the leading 12 blood suppliers in the United States. For more information on current blood inventory levels, our donor promotions, and more, see and find us @impactlifeblood on Facebook, X, Instagram, Threads, YouTube, and LinkedIn. Attachments Beleta Rush ImpactLife – World Sickle Cell Disease Awareness Day group photo Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
20 hours ago
- Business Upturn
Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) — Saudi Arabia has concluded its landmark debut at the BIO International Convention 2025, having signed more than a dozen partnerships, launched a national biotech accelerator program with Biolabs and established the Kingdom as a global hub for life sciences. Over four days, Saudi delegates showcased an ecosystem ready for collaboration across scientific discovery, clinical research, and advanced therapeutics. The Kingdom's presence spanned the entire biotech value chain – from early research to manufacturing, from regulatory frameworks to commercialization pathways. 'Saudi Arabia is stepping into biotech with intention and scale,' said His Excellency the Vice Minister of Health for Planning and Development, Eng. Abdulaziz AlRamaih. 'Biotech sits at the intersection of our health transformation and economic ambition, and we are investing with that dual mandate in mind.' Partnerships and Programs Take Center Stage Throughout the week, Saudi Arabia hosted one of the most active national pavilions at the conference, convening more than 25 entities across government, research, investment and innovation. More than a dozen new memoranda of understanding were signed with international partners, including leaders in genomics, AI-enabled diagnostics, gene therapy, and biomanufacturing. The Ministry of Health also formally launched its national biotech accelerator program in collaboration with BioLabs, welcoming an inaugural cohort of eight Saudi-founded biotech startups in areas ranging from protein engineering to precision genomics. The launch event brought together venture capitalists, researchers, and biotech executives to discuss the Kingdom's innovation momentum. The Kingdom's Super Session at BIO 2025 featured senior representatives from the Ministry of Health (MoH), the Saudi Food and Drug Authority (SFDA), the Saudi National Institute for Health (SNIH), the King Abdullah International Medical Research Center (KAIMRC), the King Faisal Specialist Hospital and Research Centre (KFSH&RC), and the Public Investment Fund (PIF). The panel revealed how Saudi Arabia is coordinating across policy, clinical infrastructure, and public investment to create a biotech ecosystem built for scale and scientific depth. In parallel, the delegation held more than 50 one-to-one meetings with global biotech firms and visited U.S. innovation hubs to explore collaboration in research, manufacturing, and translational medicine. The Kingdom also participated in a dedicated gathering for Saudi research talent studying in the United States, underscoring the Kingdom's long-term commitment to human capital in health and life sciences. Advancing Genomics and Genetic Medicine The Kingdom's ambition in genomics also drew significant interest. Through the Saudi Genome Program, the Kingdom has developed one of the region's most comprehensive population-specific genomic datasets, paving the way for earlier diagnosis, localized drug development, and new therapeutic approaches for inherited diseases. National screening efforts – led by Saudi Arabia's Public Health Authority, Weqaya – are expanding access to genetic risk detection through prenatal and newborn programs. Institutions like KFSH&RC and KAIMRC continue to drive forward clinical trials and translational research, supporting a growing pipeline of personalized treatments rooted in real-world data. Already, over 130 peer-reviewed publications have leveraged Saudi genomic data to inform rare disease research and advance precision diagnostics. The Kingdom's cell and gene therapy readiness now spans regulation, clinical trials, and talent development, with the Saudi Food and Drug Authority's fast-track approval of advanced therapies positioning it as one of the world's most agile regulators. A Platform for the Future Under the National Biotechnology Strategy, with the continued support of HRH Prince Mohammed bin Salman, Crown Prince and Prime Minister, Saudi Arabia is making biotech central to its national transformation, and the health and economic prosperity of its people. The Kingdom concludes BIO 2025 with a clear message: Saudi Arabia is open for collaboration, primed for innovation, and committed to lasting partnerships. About Saudi Biotech The Kingdom of Saudi Arabia was proud to debut its first-ever national pavilion at BIO International, being held in Boston June 16-19, 2025. Rooted in Vision 2030, this initiative showcased a fully integrated life sciences ecosystem – combining a future-ready lifestyle, world-class research institutions, streamlined regulation, and digital infrastructure built for speed, scale, and scientific impact. The Kingdom offers a seamless environment for biotech innovation with fast-track clinical trial approvals, robust regulatory alignment via its ML4-designated Food and Drug Authority, and nationwide digital platforms like NPHIES and the world's largest Virtual Hospital. Saudi Biotech brings together the Kingdom's leading health and science entities, including the Ministry of Health, Saudi Food and Drug Authority, Saudi National Institute of Health, Public Health Authority, and the Saudi Health Council, all of whom play vital roles in enabling a regulatory environment that supports clinical innovation. It also features institutions powering translational research and IP protection, such as the Research, Development and Innovation Authority, King Faisal Specialist Hospital and Research Centre, King Abdulaziz City for Science and Technology, King Abdullah University of Science and Technology, and the King Abdullah International Medical Research Center. Funding and investment facilitators were also present, including the Ministry of Investment, Ministry of Industry and Mineral Resources, and the Saudi Business Center, alongside localization powerhouses like Lifera, Lean, and the Public Investment Fund. Visitors had the opportunity to explore how talent and livability are central to the Kingdom's strategy through participation from the Royal Commission for Riyadh City and the Premium Residency Center. Finally, NEOM showcased the Kingdom's most ambitious vision – a purpose-built frontier for biotech, precision medicine, and future health. Visit to learn more. Contact:Saudi Biotech [email protected]
